First in Human Study for Huntington's Disease Led by UCL Academic
December 06, 2024
December 06, 2024
LONDON, England, Dec. 6 (TNSres) -- The University College London issued the following news:
The first patient has begun treatment on a global trial of a novel medication for Huntington's disease, led within the UK by a UCL and UCLH academic.
Professor Sarah Tabrizi, Director of the Huntington's Disease Centre, UCL Queen Square Institute of Neurology, and a consultant at UCLH, is leading the UK arm of a world-first trial of an investigational (experimental) medication f . . .
The first patient has begun treatment on a global trial of a novel medication for Huntington's disease, led within the UK by a UCL and UCLH academic.
Professor Sarah Tabrizi, Director of the Huntington's Disease Centre, UCL Queen Square Institute of Neurology, and a consultant at UCLH, is leading the UK arm of a world-first trial of an investigational (experimental) medication f . . .